A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

NCT06456580 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
180
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Vor Biopharma